Cargando…

Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC), the most common form of liver cancer, is the third leading cause of cancer-related mortality worldwide. Recent research indicates that altering the gut environment affects liver immune response and cancer progression, through what is known as the ‘gut–...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Sj, Khatiwada, Saroj, Behary, Jason, Kim, Rachel, Zekry, Amany
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104842/ https://www.ncbi.nlm.nih.gov/pubmed/35565229 http://dx.doi.org/10.3390/cancers14092099

Ejemplares similares

Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination
por: Amorim, Nadia, et al.
Publicado: (2022)

Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions
por: Rajapakse, Jayashi, et al.
Publicado: (2023)

Critical Assessment of Whole Genome and Viral Enrichment Shotgun Metagenome on the Characterization of Stool Total Virome in Hepatocellular Carcinoma Patients
por: Zhang, Fan, et al.
Publicado: (2022)

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
por: Behary, Jason, et al.
Publicado: (2021)

Radiological Diagnosis of Chronic Liver Disease and Hepatocellular Carcinoma: A Review
por: Singh, Sonit, et al.
Publicado: (2023)

Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 −/− mouse model
por: Behary, J., et al.
Publicado: (2021)

Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
por: Lapidot, Yelena, et al.
Publicado: (2020)

Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
por: Temraz, Sally, et al.
Publicado: (2021)

Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma
por: Zhang, Weizheng, et al.
Publicado: (2023)

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2023)

The Role of Gut Microbiome in Hepatocellular Carcinoma: A Systematic Review
por: Trivedi, Yash, et al.
Publicado: (2023)

Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications
por: Khatiwada, Saroj, et al.
Publicado: (2020)

Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma
por: Huang, Hechen, et al.
Publicado: (2020)

Modulation of the gut microbiome with nisin
por: O’Reilly, Catherine, et al.
Publicado: (2023)

Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma
por: Shen, Ying-Chun, et al.
Publicado: (2021)

The role of gut microbiome in immune modulation in metastatic renal cell carcinoma
por: Deluce, Jasna, et al.
Publicado: (2022)

Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
por: Zheng, Yi, et al.
Publicado: (2019)

Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
por: Chung, Min-Woo, et al.
Publicado: (2021)

Nanosecond pulse effectively ablated hepatocellular carcinoma with alterations in the gut microbiome and serum metabolites
por: Zou, Yawen, et al.
Publicado: (2023)

Mental awareness improved mild cognitive impairment and modulated gut microbiome
por: Khine, Wei Wei Thwe, et al.
Publicado: (2020)

The Gut Microbiome Modulates Colon Tumorigenesis
por: Zackular, Joseph P., et al.
Publicado: (2013)

Gut microbiome evolution impacts the clinical outcomes of diseases
por: Sun, Lejia, et al.
Publicado: (2023)

Gut-microbiome Taxonomic Profiling as Non-invasive Biomarkers for the Early Detection of Alcoholic Hepatocellular Carcinoma
por: Seok, Jun, et al.
Publicado: (2020)

Modulation of Allicin-Free Garlic on Gut Microbiome
por: Chen, Keyu, et al.
Publicado: (2020)

The gut microbiome as a modulator of healthy ageing
por: Ghosh, Tarini Shankar, et al.
Publicado: (2022)

Gut microbiome in modulating immune checkpoint inhibitors
por: Li, Xiang, et al.
Publicado: (2022)

The gut microbiome modulates the transformation of microglial subtypes
por: Huang, Yu, et al.
Publicado: (2023)

Clinical Aspects of Gut Microbiota in Hepatocellular Carcinoma Management
por: Xu, Jinghang, et al.
Publicado: (2021)

Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial
por: Lee, Delia Pei Shan, et al.
Publicado: (2022)

Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
por: Ren, Zhigang, et al.
Publicado: (2019)

Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”
por: Kang, Yong-Bo, et al.
Publicado: (2022)

The Gut Microbiome and Metastatic Renal Cell Carcinoma
por: Meza, Luis, et al.
Publicado: (2023)

Role of the Gut Microbiome in Modulating Arthritis Progression in Mice
por: Liu, Xiaofei, et al.
Publicado: (2016)

Gut microbiome modulates efficacy of immune checkpoint inhibitors
por: Yi, Ming, et al.
Publicado: (2018)

Significance of African Diets in Biotherapeutic Modulation of the Gut Microbiome
por: Isibor, PO, et al.
Publicado: (2021)

Metformin modulates the gut microbiome in broiler breeder hens
por: Van Syoc, Emily, et al.
Publicado: (2022)

Intervention with α-Ketoglutarate Ameliorates Colitis-Related Colorectal Carcinoma via Modulation of the Gut Microbiome
por: Li, Si, et al.
Publicado: (2019)

Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
por: Said, Imaad, et al.
Publicado: (2022)

Hepatocellular Carcinoma: Understanding the Inflammatory Implications of the Microbiome
por: Khalyfa, Ahamed A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4g58tf51ksmpk6nmj79ih3g668